Study guide

11.4 Stress Testing and Myocardial Perfusion Imaging

AACN Cardiac Medicine Certification CMC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview and the CMC Test Plan

1.1 CMC Exam Format, Eligibility, Fees & Scoring 1.2 The CMC Test Plan: Four Domains and How to Study Them

2 Chapter 2: Acute Coronary Syndromes and Ischemic Heart Disease

2.1 Pathophysiology & Classification of Acute Coronary Syndromes 2.2 12-Lead ECG Localization & Cardiac Biomarker Trajectories 2.3 Acute Reperfusion Strategies & Nursing Management 2.4 Complications of Acute Myocardial Infarction 2.5 Chronic Coronary Disease, Hyperlipidemia and Lipid-Lowering Therapy

3 Chapter 3: Heart Failure, Cardiomyopathies, Pericardial and Valvular Disease

3.1 Acute Decompensated Heart Failure & Staging 3.2 Acute Cardiogenic Pulmonary Edema 3.3 Dilated, Hypertrophic, and Restrictive Cardiomyopathies 3.4 Acute Pericarditis, Cardiac Tamponade & Constrictive Pericarditis 3.5 Infective Endocarditis, Myocarditis and Rheumatic Heart Disease 3.6 Valvular Heart Disease: Stenosis & Regurgitation 3.7 Syncope: Cardiac Versus Non-Cardiac Causes and Workup

4 Chapter 4: Dysrhythmias, Conduction Disorders and Electrophysiologic Interventions

4.1 Atrial Fibrillation, Atrial Flutter & Supraventricular Tachycardias 4.2 Ventricular Arrhythmias & Cardiac Arrest Management 4.3 Atrioventricular Blocks & Intraventricular Conduction Delays 4.4 Temporary Pacing: Transcutaneous, Transvenous and Epicardial 4.5 Permanent Pacemakers, CRT and Device Troubleshooting 4.6 Implantable and Wearable Cardioverter Defibrillators 4.7 Catheter Ablation and Post-Ablation Nursing Care 4.8 Synchronized Cardioversion and Defibrillation

5 Chapter 5: Vascular Conditions and Vascular Interventions

5.1 Aortic Dissection, Aortic Aneurysms & Hypertensive Crises 5.2 Peripheral Artery Disease & Acute Limb Ischemia 5.3 Acute Venous Thrombosis, DVT and VTE Prophylaxis 5.4 Peripheral and Carotid Angiography and Interventions 5.5 Endovascular Aortic Repair: EVAR and TEVAR 5.6 Catheter-Directed Thrombolysis and Post-Intervention Vascular Complications

6 Chapter 6: Shock States and Mechanical Circulatory Support

6.1 Cardiogenic Shock Pathophysiology, Hemodynamics & Etiologies 6.2 Non-Cardiogenic Shock: Hypovolemic, Distributive and Obstructive 6.3 Multisystem Organ Dysfunction Syndrome 6.4 Intra-Aortic Balloon Pump Therapy & Waveform Optimization 6.5 Percutaneous & Surgical Mechanical Circulatory Support: Impella, VA-ECMO, LVAD

7 Chapter 7: Cardiac Procedures and Structural Heart Interventions

7.1 Diagnostic Cardiac Catheterization & Coronary Angiography Interpretation 7.2 Percutaneous Coronary Intervention: Stents, No-Reflow and Post-PCI Care 7.3 Structural Heart Interventions: TAVR, MitraClip, Pericardiocentesis 7.4 Post-Cardiac Surgery Management (>48 Hours) & Late Complications

8 Chapter 8: Cardiovascular Pharmacology

8.1 Inotropes, Vasopressors & Inodilators 8.2 Vasodilators & Antianginal Agents 8.3 Antiarrhythmic Agents: Vaughan Williams Classes I-IV 8.4 Anticoagulants, Antiplatelets, Thrombolytics & Reversal Agents 8.5 Diuretics and Decongestion Strategies 8.6 Guideline-Directed Medical Therapy for Heart Failure

9 Chapter 9: Non-Cardiovascular Conditions: Pulmonary

9.1 Acute Pulmonary Embolism 9.2 Acute Respiratory Failure and ARDS 9.3 Pleural Space Abnormalities: Pneumothorax, Effusion and Hemothorax 9.4 Pulmonary Hypertension and Right Ventricular Failure 9.5 Sleep-Disordered Breathing in Cardiac Patients

10 Chapter 10: Non-Cardiovascular Conditions: Endocrine, Renal, Hematologic, Neurologic and Behavioral

10.1 Diabetes Mellitus and Glycemic Control in Cardiac Care 10.2 Thyroid and Adrenal Disorders in the Cardiac Patient 10.3 Metabolic Syndrome and Cardiometabolic Risk 10.4 Coagulopathies: Heparin-Induced Thrombocytopenia, DIC and Bleeding Disorders 10.5 Anemia and Transfusion Management in Cardiac Patients 10.6 Acute Ischemic and Hemorrhagic Stroke in the Cardiac Patient 10.7 Acute Kidney Injury and Contrast-Associated Nephropathy 10.8 Chronic Kidney Disease and the Dialysis-Dependent Cardiac Patient 10.9 Electrolyte Imbalances and Dysrhythmia Risk 10.10 Substance Use, Withdrawal and Cardiac Effects 10.11 Non-Cardiac Chest Pain: Differential and Triage 10.12 Non-Cardiovascular Multisystem Complications in Cardiac Patients

11 Chapter 11: Monitoring and Diagnostics

11.1 Pulmonary Artery Catheterization & Hemodynamic Waveform Interpretation 11.2 Arterial Line Monitoring, Continuous Cardiac Output & ScvO2 11.3 Echocardiography, Cardiac MRI & Non-Invasive Cardiac Imaging 11.4 Stress Testing and Myocardial Perfusion Imaging 11.5 Remote Cardiovascular Monitoring and Ambulatory Rhythm Devices 11.6 Laboratory Testing in Cardiac Care 11.7 Arterial Blood Gases and Acid-Base Interpretation 11.8 Pulse Oximetry, Capnography and Chest Radiography

12 Chapter 12: Respiratory, Renal and Multisystem Therapeutic Interventions

12.1 Non-Invasive Ventilation in Cardiac Patients 12.2 Invasive Mechanical Ventilation and Heart-Lung Interactions 12.3 Renal Replacement Therapy: Hemodialysis, CRRT, SCUF and Ultrafiltration 12.4 Targeted Temperature Management After Cardiac Arrest 12.5 Palliative and End-of-Life Care in Advanced Cardiac Disease

11.4 Stress Testing and Myocardial Perfusion Imaging

Key Takeaways Explain This Topic AI

A positive exercise ECG is horizontal or downsloping ST depression of at least 1 mm (0.1 mV) measured 80 ms after the J point in two contiguous leads; upsloping ST depression is non-specific and does not qualify.

The Duke Treadmill Score equals exercise time in minutes minus (5 x maximal ST deviation in mm) minus (4 x angina index, where 0 = none, 1 = non-limiting, 2 = exercise-limiting): +5 or higher is low risk with 97% 5-year survival, -10 to +4 is moderate, and -11 or lower is high risk with 65% 5-year survival.

Left bundle branch block, ventricular paced rhythm, pre-excitation, resting ST depression of 1 mm or more, LVH with strain and digoxin effect make the exercise ECG uninterpretable and mandate imaging; LBBB and paced rhythm additionally require a vasodilator rather than exercise or dobutamine to avoid a false septal defect.

Regadenoson is 0.4 mg in 5 mL given as a fixed-dose IV push over about 10 seconds with a saline flush; methylxanthines including caffeine, theophylline and aminophylline must be withheld at least 12 hours because they competitively block adenosine receptors and cause false-negative studies.

Transient ischemic dilation above roughly 1.2, a post-stress ejection fraction drop of more than 5%, and increased lung uptake are high-risk markers that can be the only clue to balanced multivessel or left main ischemia, because relative perfusion imaging looks falsely normal when every territory is underperfused.

Last updated: August 2026

Why Stress Testing Sits in the Monitoring and Diagnostics Domain

Test-plan item IV.A.5 covers stress testing and myocardial perfusion imaging . The CMC candidate is never asked to read the images. The candidate is asked to screen the patient for contraindications, hold the right drugs for the right reasons, recognise the responses that require the test to be terminated, and translate the report into a plan of care. Nearly every exam item in this area lands on one of those four things.

  • Exercise Treadmill Testing
  • Protocols

The Bruce protocol is the reference standard: three-minute stages, each raising both speed and grade.

  • Stage Speed Grade Approximate METs Cumulative time
  • 1 1.7 mph 10% 4.6 3 min
  • 2 2.5 mph 12% 7.0 6 min
  • 3 3.4 mph 14% 10.1 9 min
  • 4 4.2 mph 16% 12.9 12 min
  • 5 5.0 mph 18% 15.0 15 min

The modified Bruce protocol inserts two preliminary three-minute stages at 1.7 mph, first at 0% grade and then at 5% grade, ahead of Bruce stage 1. It is used for deconditioned, elderly and early post-infarction patients who cannot begin at 4.6 METs. Because it shifts the workload curve, exercise time from a modified Bruce is not interchangeable with standard-protocol exercise time when a Duke score is calculated.

METs, Target Heart Rate, and What Makes a Test Non-Diagnostic

Metabolic equivalents (METs) achieved are the single most powerful prognostic variable an exercise test produces, and functional capacity outperforms the ST-segment response for predicting mortality. Fewer than 5 METs carries a poor prognosis; 5 to 9 METs is intermediate; 10 METs or more predicts an excellent outcome that is not improved by revascularisation in stable disease.

Target heart rate is 85% of the age-predicted maximum , where age-predicted maximum is 220 minus age. A test stopped for fatigue or leg pain before 85% is reached, with no ischemic ECG change and no symptoms, is non-diagnostic (submaximal) , not negative. Reporting it as a negative test is a classic error, and beta-blockade is the most common reason a patient never gets there.

Interpreting the ST Response

Positive criteria: horizontal or downsloping ST-segment depression of at least 1 mm (0.1 mV) measured 80 ms after the J point, in two or more contiguous leads. Upsloping ST depression is non-specific. ST elevation of 1 mm or more in a lead without a Q wave (other than V1 or aVR) indicates transmural ischemia, localises the territory, is high risk, and is an immediate stop.

Other high-risk features on an exercise test:

  • Ischemia appearing at a low workload (stage 1, or under 5 METs) or at a heart rate below 120
  • ST depression in five or more leads, or ST depression persisting more than 5 minutes into recovery
  • Exercise-induced hypotension (systolic pressure falling below baseline with increasing workload)
  • Sustained ventricular tachycardia

Chronotropic incompetence, and an abnormal heart-rate recovery (a fall of fewer than 12 bpm at 1 minute of active recovery)

The Duke Treadmill Score

Duke Treadmill Score = exercise time in minutes minus (5 x maximal ST deviation in mm, in any lead except aVR) minus (4 x angina index), where the angina index is 0 for no angina, 1 for non-limiting angina, and 2 for angina that stopped the test.

  • Score Risk Approximate 5-year survival
  • +5 or higher Low 97%
  • 10 to +4 Moderate 90%
  • 11 or lower High 65%

A high-risk Duke score is a referral for coronary angiography, not for another non-invasive test.

  • Contraindications and Termination Criteria
  • Contraindications
  • Absolute Relative
  • Acute myocardial infarction within 2 days Known obstructive left main stenosis

Ongoing unstable angina not yet medically stabilised Moderate-to-severe aortic stenosis of uncertain symptom status

Uncontrolled arrhythmia causing symptoms or hemodynamic compromise Tachy- or bradyarrhythmias with uncontrolled ventricular rate

  • Symptomatic severe aortic stenosis Acquired advanced or complete heart block
  • Decompensated heart failure Hypertrophic cardiomyopathy with a severe resting outflow gradient

Acute pulmonary embolism, pulmonary infarction or deep vein thrombosis Recent stroke or transient ischemic attack

  • Acute myocarditis or pericarditis Resting systolic pressure above 200 or diastolic above 110 mmHg
  • Acute aortic dissection Significant anemia, electrolyte derangement, uncorrected hyperthyroidism
  • Active endocarditis Mental or physical impairment limiting cooperation
  • Absolute Indications to Stop the Test

These are the nurse's action list, and CMC items are written around them:

ST elevation of more than 1 mm in leads without Q waves (other than V1 or aVR)

A fall in systolic blood pressure of more than 10 mmHg below baseline despite increasing workload, when accompanied by any other evidence of ischemia — this signals an ischemic drop in stroke volume and is the most ominous hemodynamic finding on a treadmill

  • Moderate to severe angina
  • Central nervous system symptoms: ataxia, dizziness, near-syncope
  • Signs of poor perfusion: cyanosis, pallor, cold clammy skin

Sustained ventricular tachycardia , or any arrhythmia including second- or third-degree AV block that compromises hemodynamics

  • Technical inability to monitor the ECG or blood pressure
  • The patient's request to stop

Relative indications include marked ST depression of more than 2 mm horizontal or downsloping, systolic pressure above 250 or diastolic above 115 mmHg, increasing chest pain, severe fatigue or wheezing, and a new bundle branch block that cannot be distinguished from ventricular tachycardia.

Baseline ECG Abnormalities That Force Imaging

An exercise ECG cannot be interpreted when the resting ST segment is already abnormal. Send these patients directly for an imaging-based study:

Baseline finding Why the exercise ECG fails Preferred stress modality

Left bundle branch block Secondary repolarisation abnormality; exercise or dobutamine also creates a false anteroseptal perfusion defect from delayed septal activation and shortened diastole Vasodilator perfusion imaging (regadenoson, adenosine, dipyridamole)

  • Ventricular paced rhythm Same repolarisation and septal-activation problem Vasodilator perfusion imaging
  • Pre-excitation (WPW) Delta wave distorts the ST segment Vasodilator perfusion imaging
  • Resting ST depression of 1 mm or more No interpretable baseline to deviate from Imaging with any stressor
  • LVH with repolarisation change (strain) High false-positive rate Imaging with any stressor

Digoxin effect Scooped ST depression mimics ischemia; can persist 2 weeks after stopping Imaging with any stressor

Exercise remains preferred whenever the patient can walk and the ECG is interpretable, because it supplies functional capacity, symptom reproduction and heart-rate recovery data that no pharmacologic test provides.

  • Pharmacologic Stress Agents
  • Vasodilators

Agent Adult dose Mechanism Reversal

Regadenoson 0.4 mg in 5 mL as a single fixed-dose IV push over about 10 seconds, followed by a 5 mL saline flush; no weight adjustment, no pump Selective adenosine A2A receptor agonist Aminophylline 50-250 mg slow IV (label describes 100 mg over 60 seconds)

Adenosine 140 mcg/kg/min IV infusion over 4-6 minutes Non-selective A1, A2A, A2B and A3 agonist Stop the infusion; half-life is under 10 seconds. Aminophylline for persistent effects

Dipyridamole 0.56 mg/kg IV over 4 minutes Blocks cellular adenosine reuptake, raising endogenous adenosine Aminophylline is frequently required because the half-life is long

Mechanism to understand, not memorise. Vasodilators triple to quadruple flow through normal coronary arteries. A vessel distal to a significant stenosis is already maximally dilated at rest and cannot increase flow further. The result is flow heterogeneity , not true ischemia in most patients — the tracer distributes preferentially to normal territory and the stenotic territory appears as a relative defect. Coronary steal is the exception: when a territory depends on collaterals, dilating the donor bed diverts flow away from it and produces genuine ischemia with chest pain and ST-segment change.

Contraindications to vasodilator stress: second-degree Mobitz II or third-degree AV block, or sinus node dysfunction, without a functioning pacemaker; systolic blood pressure below 90 mmHg; acute coronary syndrome or unstable angina within 48 hours. Adenosine and dipyridamole are additionally contraindicated in active bronchospasm or severe reactive airway disease because A2B and A3 stimulation constricts airways. Regadenoson is A2A selective and is the usual choice in stable COPD or mild asthma, but bronchoconstriction has still been reported, so the bronchodilator stays at the bedside.

The caffeine rule. Methylxanthines — caffeinated coffee, tea, cola, energy drinks, chocolate, and drug products including theophylline and aminophylline — are competitive adenosine-receptor antagonists. They blunt the hyperemic response and produce false-negative studies . Withhold all caffeine for at least 12 hours (many laboratories require 24) and theophylline preparations for 12 to 48 hours per protocol. Also hold dipyridamole-containing products such as aspirin-dipyridamole for 24 to 48 hours before a dipyridamole or adenosine study. Expect flushing, chest tightness, dyspnea, headache, metallic taste and transient AV block; these are drug effects, not automatically ischemia, and they resolve within minutes.

Dobutamine

Used when vasodilators are contraindicated (severe bronchospasm, unavoidable recent caffeine, high-grade block without a pacer) and as the standard stressor for viability assessment on stress echocardiography . Start at 5 to 10 mcg/kg/min, escalate by 10 mcg/kg/min every 3 minutes to a maximum of 40 mcg/kg/min, and add atropine 0.25 to 0.5 mg IV in divided doses (commonly to 1-2 mg total) if the target heart rate is not reached. Risks are atrial and ventricular arrhythmia, hypotension from a dynamic left ventricular outflow gradient, and severe hypertension. Because the half-life is about 2 minutes, stopping the infusion usually suffices; a short-acting beta blocker such as esmolol is the antidote. Beta blockers blunt the response, so they are typically held before a dobutamine study.

Imaging Modalities and How to Read the Report

Modality What it measures Notes for the nurse

SPECT MPI (technetium-99m sestamibi or tetrofosmin, occasionally thallium-201) Relative regional perfusion at stress and rest Most widely available; attenuation artifact from breast tissue (anterior) and diaphragm (inferior)

PET MPI (rubidium-82, N-13 ammonia) Perfusion plus absolute myocardial blood flow and myocardial flow reserve Higher resolution, lower radiation, superior in obesity; flow reserve below about 2.0 unmasks balanced multivessel and microvascular disease

Stress echocardiography Regional wall motion in a 16- or 17-segment model Ischemia = new or worsening wall-motion abnormality; scar = fixed akinesis; biphasic response (improves at low-dose dobutamine, worsens at high dose) = viable hibernating myocardium

Stress cardiac MRI Perfusion plus late gadolinium enhancement for scar No ionising radiation; gadolinium caution in advanced renal impairment; not for most non-conditional devices

Coronary CT angiography with FFR-CT Anatomy plus lesion-specific physiology; FFR-CT of 0.80 or lower indicates ischemia Requires heart-rate control (often oral or IV metoprolol to below 60) and sublingual nitroglycerin; iodinated contrast and renal screening

Coronary artery calcium score Non-contrast Agatston score of calcified plaque A score of zero is a strong negative for primary prevention; a score of 100 or more, or above the 75th percentile, favours statin therapy. It is not a stress test and cannot diagnose ischemia

Reading a Perfusion Study

Reversible defect — present on stress images, absent or improved at rest = ischemia .

Fixed defect — present on both = scar , or an attenuation artifact. Check gated wall motion: if the wall in question moves and thickens normally, it is artifact, not scar.

Partially reversible — infarct with surrounding peri-infarct ischemia.

Transient ischemic dilation (TID) — the left ventricular cavity appears larger on post-stress images; a ratio above roughly 1.2 signals severe multivessel or left main disease.

Post-stress ejection fraction drop of more than 5%, a stress EF below 45%, or increased lung uptake — high risk.

Balanced ischemia is the trap. Relative perfusion imaging compares one territory against another. In left main or triple-vessel disease every territory is underperfused, so the relative images can look uniform and be called normal. TID, the post-stress EF fall, an abnormal PET flow reserve and the clinical picture are what catch it.

Nursing Responsibilities

NPO 3 to 4 hours (some protocols 4 to 6). No caffeine for 12 to 24 hours. Confirm the hold verbally on arrival — patients frequently forget decaffeinated is not caffeine-free.

Medication holds. Beta blockers, non-dihydropyridine calcium channel blockers and long-acting nitrates are held 24 to 48 hours before a diagnostic exercise test so the patient can reach target heart rate. Do not hold them when the purpose of the test is to evaluate the adequacy of anti-anginal therapy, after recent acute coronary syndrome, in aortic dissection or thyrotoxicosis, or where abrupt beta-blocker withdrawal risks rebound ischemia — and never hold a cardiac medication without an order.

IV access , baseline 12-lead ECG and blood pressure, continuous ECG with blood pressure at every stage and at intervals through recovery, and a checked defibrillator and emergency drugs immediately available.

Screening : pregnancy and lactation before any radiotracer, weight limits on the table, ability to walk, recent contrast and renal function, and current glycemic management (diabetic patients typically take half their usual insulin with the NPO order).

Recovery is not downtime. ST-segment depression that appears only in recovery is a genuine positive result, and arrhythmia and hypotension frequently occur after exercise stops as venous return falls. Keep the patient monitored until heart rate, blood pressure and the ECG return to baseline, encourage fluids and voiding to clear the tracer, and document symptom onset and resolution times.